Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 172

Работа: A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

  1. Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection From Toxic Damage Induced by Chemotherapy

    Maria Cristina Comelli, U. Mengs, Carl Christoph Schneider +1

    Обзорная статья2007Цитирований: 4
    ABI

  2. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

    Peter Surai

    Обзорная статья2015Цитирований: 4
    ABI

  3. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP

    W. Zhu

    Статья2001Цитирований: 4
    ABI

  4. Silybin and Silymarin - New and Emerging Applications in Medicine

    Radek Gažák, Daniela Walterová, Vladimı́r Křen

    Обзорная статья2007Цитирований: 4
    ABI

  5. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity

    Michaela Pyszková, Michal Biler, David Biedermann +11

    Статья2015Цитирований: 4
    ABI

  6. Preparation, Pharmacokinetics and Body Distribution of Silymarin-Loaded Solid Lipid Nanoparticles After Oral Administration

    Jun He, Shi-xiang Hou, Weigen Lu +2

    Статья2007Цитирований: 4
    ABI

  7. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells

    Tiancong Wu, Wen Liu, Wenjie Guo +1

    Статья2016Цитирований: 4
    ABI

  8. Silymarin for Liver Disease

    Ludovico Abenavoli, Nataša Milić

    Глава2017Цитирований: 4
    ABI

  9. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells

    Lenka Roubalová, Albena T. Dinkova‐Kostova, David Biedermann +3

    Статья2017Цитирований: 4
    ABI

  10. Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability

    Amrita Nagi, Babar Iqbal, Shobhit Kumar +3

    Статья2017Цитирований: 4
    ABI

  11. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties

    Fatih Mehmet Kandemır, Sefa Küçükler, Cüneyt Çağlayan +3

    Статья2017Цитирований: 4
    ABI

  12. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies

    Haneen Amawi, Noor Hussein, Chandrabose Karthikeyan +7

    Статья2017Цитирований: 4
    ABI

  13. Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics

    Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan +8

    Обзорная статья2018Цитирований: 4
    ABI

  14. Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells

    Maryam Mombeini, Ghasem Saki, Layasadat Khorsandi +1

    Статья2018Цитирований: 4
    ABI

  15. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases

    Abdoh Taleb, Khalil Ali Ahmad, Awais Ullah Ihsan +6

    Обзорная статья2018Цитирований: 4
    ABI

  16. Silymarin Nanoformulation as Potential Anticancer Agent in Experimental Ehrlich Ascites Carcinoma-Bearing Animals

    Mohamed El‐Far, Neven Salah, Alaa Essam +2

    Статья2018Цитирований: 4
    ABI

  17. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization

    Abid Mehmood Yousaf, Usman Rashid Malik, Yasser Shahzad +2

    Статья2018Цитирований: 4
    ABI

  18. Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media

    Samantha Drouet, Joël Doussot, Laurine Garros +6

    Статья2018Цитирований: 4
    ABI

  19. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

    Ahmed H. Ibrahim, Emil Rosqvist, Jan‐Henrik Smått +5

    Статья2019Цитирований: 4
    ABI

  20. Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation

    Sarah Nasr, Maha M. A. Nasra, Heba A. Hazzah +1

    Статья2019Цитирований: 4
    ABI

  21. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review

    Vahid Soleimani, Parisa Sadat Delghandi, Seyed Adel Moallem +1

    Обзорная статья2019Цитирований: 4
    ABI

  22. A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts

    Alena Rajnochová Svobodová, Eva Gabrielová, Jitka Ulrichová +3

    Статья2019Цитирований: 4
    ABI

  23. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art

    Alfonso Di Costanzo, Ruggero Angelico

    Обзорная статья2019Цитирований: 4
    ABI

  24. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer

    Tahereh Hosseinabadi, Zahra Lorigooini, Maryam Tabarzad +4

    Обзорная статья2019Цитирований: 4
    ABI

  25. Inhibition of urinary bladder cancer cell proliferation by silibinin

    Tatiane Martins Barcelos Barros, Ana Paula Braga Lima, Tamires Cunha Almeida +1

    Статья2020Цитирований: 4
    ABI